GASTROESOPHAGEAL REFLUX DISEASE: PREVALENCE RATE, RISK FACTORS, NEW APPROACHES TO REMEDIAL TREATMENT

Kalinichenko N. V., Dragomiretska N. V., Gushcha S. G., Zabolotna I. B., Kulchitskaya A. I. GASTROESOPHAGEAL REFLUX DISEASE: PREVALENCE RATE, RISK FACTORS, NEW APPROACHES TO REMEDIAL TREATMENT. ВІСНИК МОРСЬКОЇ МЕДИЦИНИ. 2019;1(82):65-73. ISSN 0049-6804. DOI http://dx.doi.org/10.5281/zenodo.2639562

http://www.herald.com.ua

УДК 616.329-002.2-085: 615.2+615.327

DOI http://dx.doi.org/10.5281/zenodo.2639562

GASTROESOPHAGEAL REFLUX DISEASE: PREVALENCE RATE, RISK FACTORS, NEW APPROACHES TO REMEDIAL TREATMENT

Kalinichenko N. V., Dragomiretska N. V., Gushcha S. G., Zabolotna I. B.,

Kulchitskaya A. I.

State institution «Ukrainian Research Institute of Medical Rehabilitation and Resort Therapy of Ministry of Health of Ukraine», Odessa; Military-Medical Clinical Centre of the Southern Region, Odessa;

е-mail: mrik@kurort.odessa.net

Summary. Kalinichenko N. V., Dragomiretska N. V., Gushcha S. G., Zabolotna I. B., Kulchitskaya A. I. GASTROESOPHAGEAL REFLUX DISEASE: PREVALENCE RATE, RISK FACTORS, NEW APPROACHES TO REMEDIAL TREATMENT. - State institution «Ukrainian Research Institute of Medical Rehabilitation and Resort Therapy of Ministry of Health of Ukraine», Odessa; Military-Medical Clinical Centre of the Southern Region, Odessa; е-mail: mrik@kurort.odessa.net. In the article presented the numerous data of domestic and foreign scholars on the etiopathogenesis of gastroesophageal reflux disease (GERD) and its course against the background of comorbidities (chronic cholecystitis, chronic pancreatitis, non-alcoholic fatty liver disease) atr summarized. The expediency of the development and application of complex therapy of patients with GERD is justified, taking into account all components of the pathogenesis of this disease and comorbidities. The proposed complex includes: the appointment of a standard drug therapy (drugs of the proton pump inhibitor group), the use of preformed physical factors (magnetic therapy, electrosontherapy and amplipulse therapy), an internal intake of moderately mineralized magnesium sulphate and hydrocarbonate boron waters and peloidotherapy. The treatment complex is aimed at restoring the functional state of the hepatopancreatobiliary system, reducing the manifestations of the disease, which will increase the effectiveness of treatment, improve the quality of life of patients and prevent the development of severe complications of GERD.

Key words: gastroesophageal reflux disease, acid pocket, antisecretory therapy, mineral water, physiotherapeutic therapy.